how long stay on semaglutide Does in Your System After Stopping How Long Do You Stay

J Diabetes Investig

Known side effects (class effects similar to other GLP-1 medications) Gastrointestinal issues (very common): Nausea: 38-43% of participants vs 11% placebo Diarrhea: 33-35% vs 13% placebo Vomiting: 20-21% vs 0% placebo Constipation: 22-25% vs 9% placebo Decreased appetite: 18-19% vs 9% placebo These are expected with incretin-based therapies and typically improve over time as your body adjusts

While the reward system evolved to allow us to develop habits necessary for survival for example, eating or finding a romantic partner substances such as alcohol trigger dopamine release artificially

This medication is used once weekly, while some patients may need more regular dosing